Ingersoll Rand Inc.

The full register, from 13F filings

The Register tab above is hand research: a dozen holders, each traced to the filing it came from. This asks the same question of the whole market for the quarter ended 31-mar-2026, where 879 managers reported a position. Broad where the research is deep, and shallow in the ways a 13F always is.

Built from 13F filings, which report US listed, long, US custodied positions only. A register from this source is a floor rather than a level: a holder's true position can be far larger, as BlackRock's ASML stake shows at 1.28m shares in a 13F against 26.3m in its 13G/A. Holdings held through derivatives, outside US custody, or below a manager's reporting obligation do not appear. Where a holder is marked as a family, its total sums several separate filing entities and describes something no single filing describes; the constituent entities and their share counts are listed so the total can be checked. That roll-up can legitimately exceed the family's own Schedule 13G, because a 13G is filed by one legal entity: Vanguard reports Alphabet through ten advisory entities, and The Vanguard Group Inc itself reported zero after its January 2026 disaggregation.

What a reader needs to know to read these numbers

• KKR fully exited Ingersoll Rand: not a current holder, therefore no register row. KKR North America Fund XI L.P. (CIK 0001541293) and related KKR reporting persons filed a Schedule 13G/A on 10 Feb 2022 (accession 0001140361-22-004531, CUSIP 45687V106) reporting AGGREGATE AMOUNT BENEFICIALLY OWNED = 0 and PERCENT OF CLASS = 0%, as of the 31 Dec 2021 event date. No SC 13D or SC 13G has been filed on Ingersoll Rand by any KKR-affiliated reporting person since. The 2026 DEF 14A's 5% beneficial-ownership table (Vanguard, Capital World Investors, BlackRock, T. Rowe Price Investment Management) does not list KKR. data/research/kkr.json's own holdings array does not include Ingersoll Rand at all; the two files agree KKR holds no current IR position.
• Holdings side: exactly one holding found, a 45% common equity interest (equity method) in the legacy High Pressure Solutions (HPS) upstream oil and gas business, a private entity, per Note 25 'Equity Method Investment' of the FY2025 10-K and Note 21 of the Q2 2026 10-Q (unchanged). Carrying value was fully impaired to $0.0 million as of 31 Dec 2025 (from $128.6 million at 31 Dec 2024) after a $120.9 million impairment charge in Q2 2025; value_usd is recorded as this filed $0.0 million figure rather than left null, since it is a stated figure, not an invented one.
• Search for further holdings: FY2025 10-K and Q2 2026 10-Q full-text searched for 'equity method', 'joint venture', 'unconsolidated', 'non-marketable', 'minority interest', 'variable interest entity', 'VIE' and 'investments in'. Only the single HPS equity-method investment surfaced; no other equity-method, unconsolidated, non-marketable, VIE, or minority-interest disclosure was found in either filing. Exhibit 21 to the FY2025 10-K (subsidiaries list) was checked for an ownership-percentage column of the kind that surfaced partly owned entities at PPG and Quest Diagnostics elsewhere in this project; it is a bare Entity Name / Domestic Jurisdiction list with no percentage column and no other technique available to size partial ownership from it, a genuine negative rather than an unexplored gap.
• Register self-gate, computed the way the chart computes it (from the final file on disk): 10 rows, none with rolls_up_into and none reduced (the officer/director aggregate has no members rolling into it, so it counts at full value). Raw share sum: 63,903,368 (Capital Group) + 45,129,643 (Vanguard) + 30,300,264 (BlackRock) + 27,030,168 (T. Rowe Associates) + 16,076,881 (T. Rowe Investment Management) + 15,916,822 (State Street) + 13,278,782 (FMR) + 10,642,725 (JPMorgan) + 9,700,004 (Geode) + 1,922,233 (officers/directors group) = 233,900,890 shares, or 60.28% of shares_outstanding (387,999,429). This is above the brief's roughly-25-to-45% typical band and above its 55% outer bound. Investigated for double counting and found none: every institutional row is fresh Q2 2026 13F-HR data for CUSIP 45687V106 common stock only (JPMorgan's derivative line and Vanguard/Capital Group sibling entities were each checked once, not duplicated), and the officer/director row is a distinct instrument (proxy beneficial ownership, not 13F). The high total is corroborated rather than contradicted by third-party aggregator data (not used for any figure here): a web search found total institutional ownership of Ingersoll Rand reported around 97 to 105% (aggregator methodology, likely double-counting some positions), consistent with the top 9 institutional holders alone reaching roughly 60% of the company. Corroborated first-hand by the coordinator against a source independent of any aggregator, and the aggregator figure cited above is NOT relied on: an institutional ownership reading of 97 to 105 per cent is impossible as stated and is the well known artifact of aggregators double counting shared voting and dispositive power. The measured figure from this project's own 13F-derived register (data/registers/IR.json, period 31 Mar 2026, built by a separate pipeline from the bulk 13F data) is 356,541,282 shares, 91.89% of the same denominator, with its top ten holders alone at 68.39%. The ten rows in this file sum to 60.28%, BELOW that independent top-ten figure, so this register is conservative rather than inflated and no double count is present.
• Vanguard: parent CIK 0000102909 (Vanguard Group Inc) filed Form 13F-NT (notice, no holdings) for Q2 2026, so per the successor rule the eight reporting successor entities were summed rather than substituted with a single row. Capital Group: all six Capital Group family registrants (Capital World Investors, Capital Research Global Investors, Capital International Investors, Capital International Inc/CA, Capital International Sarl, Capital International Ltd /CA/) were checked individually and summed; none omitted.
• T. Rowe Price: both CIKs (Associates 0000080255 and Investment Management 0001897612) file information-table values in THOUSANDS of dollars; both rows here were rescaled x1000 and cross-checked against the implied price per share ($82.0) on other holders' fresh Q2 2026 rows for the same CUSIP and date.